Full Press Release Details
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in February:
Guggenheim Healthcare Talks Oncology Day – Participating in a fireside chat on Wednesday, February 8, 2023, at 3:20 p.m. ET.
Citi’s 2023 Virtual Oncology Leadership Summit – Participating in a fireside chat on Wednesday, February 22, 2023, at 11:00 a.m. ET.
Live webcasts of the discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer